98 related articles for article (PubMed ID: 16579980)
1. Historical milestones in measurement of HDL-cholesterol: impact on clinical and laboratory practice.
Langlois MR; Blaton VH
Clin Chim Acta; 2006 Jul; 369(2):168-78. PubMed ID: 16579980
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
Hoang MP; Hirany SV; Parupia J; Devaraj S; Jialal I
Arch Pathol Lab Med; 1998 Nov; 122(11):1005-9. PubMed ID: 9822130
[TBL] [Abstract][Full Text] [Related]
3. [Development of measurement methods and contributions to medical care in the clinical laboratory].
Sugiuchi H
Rinsho Byori; 2008 Jan; 56(1):66-71. PubMed ID: 18318234
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidaemia in diabetic patients: time for a rethink.
Shepherd J
Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and coronary events. The current thinking.
Jones PH
Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
[TBL] [Abstract][Full Text] [Related]
6. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
7. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
8. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
[TBL] [Abstract][Full Text] [Related]
9. [Development of homogeneous assay for HDL-C in serum].
Sugiuchi H; Okabe H
Rinsho Byori; 2002 Mar; 50(3):226-33. PubMed ID: 11985048
[TBL] [Abstract][Full Text] [Related]
10. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M
Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005
[TBL] [Abstract][Full Text] [Related]
11. Novel use of the Friedewald formula to tackle anomalous HDL-C results in two cases of paraproteinaemia.
Pang RW; Tam SC
Clin Biochem; 2004 Mar; 37(3):238-40. PubMed ID: 14972647
[TBL] [Abstract][Full Text] [Related]
12. HDL cholesterol: physiology, pathophysiology, and management.
Link JJ; Rohatgi A; de Lemos JA
Curr Probl Cardiol; 2007 May; 32(5):268-314. PubMed ID: 17481993
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments.
Dale RA; Jensen LH; Krantz MJ
Ann Pharmacother; 2008 May; 42(5):633-9. PubMed ID: 18413684
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
deGoma EM; Leeper NJ; Heidenreich PA
J Am Coll Cardiol; 2008 Jan; 51(1):49-55. PubMed ID: 18174036
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
16. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
17. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
18. Advanced lipoprotein testing: recommendations based on current evidence.
Lau JF; Smith DA
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):1-31. PubMed ID: 19217510
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
Palaniappan LP; Kwan AC; Abbasi F; Lamendola C; McLaughlin TL; Reaven GM
Metabolism; 2007 Jul; 56(7):899-904. PubMed ID: 17570249
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey.
Farnier M; Garnier P; Yau C; Dejager S; Verpilleux MP
Int J Clin Pract; 2006 Oct; 60(10):1166-71. PubMed ID: 16942588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
